The residual gap-aware transformer reduces MSE by 13.1% and boosts correlation by 26.4% over a mixed-effects baseline in predicting 24-month CDR-SB change on anchored ADNI data.
Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR-SB
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
cs.LG 1years
2026 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Forecasting Medium-Horizon Alzheimer's Disease Progression: Residual Gap-Aware Transformers for 24-Month CDR-SB Change from ADNI Clinical and Biomarker Histories
The residual gap-aware transformer reduces MSE by 13.1% and boosts correlation by 26.4% over a mixed-effects baseline in predicting 24-month CDR-SB change on anchored ADNI data.